Popular
Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
CardiologyEvolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
Galderma FCBCure SoS Hub Chovatiya Video 2
Practical DermatologyGalderma FCBCure SoS Hub Chovatiya Video 2
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
CME/CE Virtual EventRedefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
Understanding the Effect of Targeting IL-17A/F in Psoriatic Arthritis
Practical Dermatology: IL-17 Journal ClubUnderstanding the Effect of Targeting IL-17A/F in Psoriatic Arthritis
Understanding the Skin–Mind Connection in Neurocosmetics
Modern AestheticsUnderstanding the Skin–Mind Connection in Neurocosmetics
Programs
Understanding the Effect of Targeting IL-17A/F in Psoriatic Arthritis
Practical Dermatology: IL-17 Journal ClubUnderstanding the Effect of Targeting IL-17A/F in Psoriatic Arthritis
Confronting Antisemitism in Medicine and Dermatology
Modern AestheticsConfronting Antisemitism in Medicine and Dermatology
Fractional Micro-Coring for Weight Loss Laxity
Modern AestheticsFractional Micro-Coring for Weight Loss Laxity
CO2 Laser Therapy to Improve Pain, Pliability, and Scar Coloration for a Wounded Soldier
Modern AestheticsCO2 Laser Therapy to Improve Pain, Pliability, and Scar Coloration for a Wounded Soldier
Expert Consensus Addresses Complication Management in Ablative Facial Resurfacing
Modern AestheticsExpert Consensus Addresses Complication Management in Ablative Facial Resurfacing
Clinical Practice
Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
CardiologyEvolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular HealthLogistical Considerations with Anti-VEGF Treatment in Wet AMD
Improving CRC Screening Uptake: An Integrated Approach
Clinician's RoundtableImproving CRC Screening Uptake: An Integrated Approach
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
CardiologyHypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
CME/CEEarly Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
Venetoclax and Palbociclib in AML: Exploring New Findings
On the Frontlines of AML/ALLVenetoclax and Palbociclib in AML: Exploring New Findings
Doctors Lounge
"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
The Convergence"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
Disparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
Clinician's RoundtableDisparities in Acne Prescribing Patterns Highlight Structural and Racial Gaps
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Rub Some Dirt In ItMessy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Death by Planet? Strange Diagnoses from 1632 London’s Medical Records
Rub Some Dirt In ItDeath by Planet? Strange Diagnoses from 1632 London’s Medical Records
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple SclerosisUncovering Disparities in Teleneurology Utilization Post-Pandemic
CME
- NEW EPISODE
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
MinuteCE®From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
- NEW EPISODE
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
MinuteCE®From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
- NEW EPISODE
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
MinuteCE®Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
- NEW EPISODE
Cracking the Code of Obstruction: Unmet Needs in oHCM
MinuteCE®Cracking the Code of Obstruction: Unmet Needs in oHCM
When to Begin FcRn: Initiation Criteria, Key Evidence
MinuteCE®When to Begin FcRn: Initiation Criteria, Key Evidence
Turning Flares Into Function: Flag Uncontrolled Disease
MinuteCE®Turning Flares Into Function: Flag Uncontrolled Disease
Industry Feature
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry FeatureTreating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry FeatureBreakthrough Technology Improves Concussion Assessment and Player Safety
Groundbreaking AI Models Transform Cardiovascular Diagnosis
Medical Industry FeatureGroundbreaking AI Models Transform Cardiovascular Diagnosis